College of Psychiatric and Neurologic Pharmacists

Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants -- potentially, half a million US children.

View the original article